1959 年 2 巻 2 号 p. 148-153,175
The treatment of paranasal sinnsitis of children has been generally considered to be a matter of difficulty in its clinical management. The clinical course of this diseases in children is subject to transient changes of general condition or their constitutional tendency compared with that in adults.
The purposes of this paper is to introduce a new therapeutic agent of asthma, namely “Asgen, ” which was revealed to be available for the treatment of sinusitis of children.
The therapy with this drugs was attempted to a series of 32 cases of sinusitis of sinusitis of children by means of peroral administration or nebulizer easily applied for children.
The results of this treatment revealed the drug to be highly effective in five cases (15.6%) and effective in sixteen cases (50%).
The authors also made an investigation of these cases with regard to the pathological aspect of the paransal sinuses and the presence of idiosyncracy.
As a result of this study, this drug was found to be expectable to a considerable extent as a therapeutic agent for patients with relatively marked changes of the sinuses and high idiosycracy, namely, those associated with so-called allergic disease.